| # | Title | Journal | Year | Citations |
|---|
|
| 1 | Acute Blood Pressure Lowering, Vasoprotective, and Antiplatelet Properties of Dietary Nitrate via Bioconversion to Nitrite | Hypertension | 2008 | 907 |
| 2 | Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial | Lancet, The | 2016 | 826 |
| 3 | The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulation | Atherosclerosis | 2015 | 613 |
| 4 | The Pathogenetic Role of Cortisol in the Metabolic Syndrome: A Hypothesis | Journal of Clinical Endocrinology and Metabolism | 2009 | 527 |
| 5 | Non-alcoholic fatty liver disease and dyslipidemia: An update | Metabolism: Clinical and Experimental | 2016 | 397 |
| 6 | Position paper Statin intolerance – an attempt at a unified definition. Position paper from an International Lipid Expert Panel | Archives of Medical Science | 2015 | 318 |
| 7 | The Relation Between Atherosclerosis and the Neutrophil–Lymphocyte Ratio | Clinical and Applied Thrombosis/Hemostasis | 2016 | 289 |
| 8 | Effects of Quercetin on Blood Pressure: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials | Journal of the American Heart Association | 2016 | 221 |
| 9 | The Role of Nutraceuticals in Statin Intolerant Patients | Journal of the American College of Cardiology | 2018 | 221 |
| 10 | Prospective Study Using the Risk of Ovarian Cancer Algorithm to Screen for Ovarian Cancer | Journal of Clinical Oncology | 2005 | 218 |
| 11 | Leptin, cardiovascular diseases and type 2 diabetes mellitus | Acta Pharmacologica Sinica | 2018 | 217 |
| 12 | The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement | Metabolism: Clinical and Experimental | 2017 | 216 |
| 13 | Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel | Archives of Medical Science | 2017 | 213 |
| 14 | The effect of smoking on arterial stiffness | Hypertension Research | 2010 | 171 |
| 15 | Socio-economic status is associated with epigenetic differences in the pSoBid cohort | International Journal of Epidemiology | 2012 | 170 |
| 16 | Endocan: A novel inflammatory indicator in cardiovascular disease? | Atherosclerosis | 2015 | 166 |
| 17 | Parathyroid Hormone Stimulates the Proliferation of Cells Derived from Human Bone* | Endocrinology | 1986 | 160 |
| 18 | Analysis of vitamin D levels in patients with and without statin-associated myalgia — A systematic review and meta-analysis of 7 studies with 2420 patients | International Journal of Cardiology | 2015 | 157 |
| 19 | Statin therapy and plasma coenzyme Q10 concentrations—A systematic review and meta-analysis of placebo-controlled trials | Pharmacological Research | 2015 | 154 |
| 20 | Primary hyperoxaluria type 1: update and additional mutation analysis of theAGXTgene | Human Mutation | 2009 | 153 |
| 21 | Atherosclerosis and osteoporosis: age-dependent degenerative processes or related entities? | Osteoporosis International | 2009 | 149 |
| 22 | Statin therapy reduces plasma endothelin-1 concentrations: A meta-analysis of 15 randomized controlled trials | Atherosclerosis | 2015 | 149 |
| 23 | Impact of statin therapy on plasma adiponectin concentrations: A systematic review and meta-analysis of 43 randomized controlled trial arms | Atherosclerosis | 2016 | 149 |
| 24 | A review of the carotid and femoral intima-media thickness as an indicator of the presence of peripheral vascular disease and cardiovascular risk factors | Cardiovascular Research | 2002 | 148 |
| 25 | A systematic review and meta-analysis of the effect of statins on plasma asymmetric dimethylarginine concentrations | Scientific Reports | 2015 | 146 |
| 26 | Lack of efficacy of resveratrol on C-reactive protein and selected cardiovascular risk factors — Results from a systematic review and meta-analysis of randomized controlled trials | International Journal of Cardiology | 2015 | 146 |
| 27 | Endothelial dysfunction in metabolic syndrome: Prevalence, pathogenesis and management | Nutrition, Metabolism and Cardiovascular Diseases | 2010 | 143 |
| 28 | Arterial Stiffness in the Heart Disease of CKD | Journal of the American Society of Nephrology: JASN | 2019 | 142 |
| 29 | Platelet function in rheumatoid arthritis: arthritic and cardiovascular implications | Rheumatology International | 2011 | 137 |
| 30 | Adiponectin, lipids and atherosclerosis | Current Opinion in Lipidology | 2017 | 136 |
| 31 | Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk | Metabolism: Clinical and Experimental | 2021 | 127 |
| 32 | Lipoprotein Subfractions in Metabolic Syndrome and Obesity: Clinical Significance and Therapeutic Approaches | Nutrients | 2013 | 126 |
| 33 | Glucagon-like peptide-1-based therapies and cardiovascular disease: looking beyond glycaemic control | Diabetes, Obesity and Metabolism | 2011 | 123 |
| 34 | Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism | Expert Opinion on Pharmacotherapy | 2008 | 116 |
| 35 | Cilostazol for intermittent claudication | The Cochrane Library | 2014 | 115 |
| 36 | Lipid accumulation product and triglycerides/glucose index are useful predictors of insulin resistance | Journal of Diabetes and Its Complications | 2018 | 115 |
| 37 | Peroxynitrite and Brain Mitochondria: Evidence for Increased Proton Leak | Journal of Neurochemistry | 1998 | 112 |
| 38 | Lower carbohydrate diets and all-cause and cause-specific mortality: a population-based cohort study and pooling of prospective studies | European Heart Journal | 2019 | 112 |
| 39 | Safety of red yeast rice supplementation: A systematic review and meta-analysis of randomized controlled trials | Pharmacological Research | 2019 | 101 |
| 40 | Comparison of four definitions of the metabolic syndrome in a Greek (Mediterranean) population | Current Medical Research and Opinion | 2010 | 93 |
| 41 | Statins decrease all-cause mortality only in CKD patients not requiring dialysis therapy—A meta-analysis of 11 randomized controlled trials involving 21,295 participants | Pharmacological Research | 2013 | 92 |
| 42 | Is Nonalcoholic Fatty Liver Disease Indeed the Hepatic Manifestation of Metabolic Syndrome? | Current Vascular Pharmacology | 2018 | 92 |
| 43 | Dietary inflammatory index and cardiometabolic risk in US adults | Atherosclerosis | 2018 | 91 |
| 44 | Introducing the ‘Drucebo’ effect in statin therapy: a systematic review of studies comparing reported rates of statin‐associated muscle symptoms, under blinded and open‐label conditions | Journal of Cachexia, Sarcopenia and Muscle | 2018 | 89 |
| 45 | 11beta-Hydroxysteroid dehydrogenase type 1 inhibitors: novel agents for the treatment of metabolic syndrome and obesity-related disorders? | Metabolism: Clinical and Experimental | 2013 | 88 |
| 46 | The impact of type of dietary protein, animal versus vegetable, in modifying cardiometabolic risk factors: A position paper from the International Lipid Expert Panel (ILEP) | Clinical Nutrition | 2021 | 88 |
| 47 | Acute pancreatitis in pregnancy: an overview | European Journal of Obstetrics, Gynecology and Reproductive Biology | 2011 | 87 |
| 48 | The mechanisms of atrial fibrillation in hyperthyroidism | Thyroid Research | 2009 | 85 |
| 49 | Mean Platelet Volume and Platelet Distribution Width in non-diabetic subjects with Obstructive Sleep Apnoea Syndrome: New indices of severity? | Platelets | 2012 | 82 |
| 50 | Do we need to consider inflammatory markers when we treat atherosclerotic disease? | Atherosclerosis | 2008 | 80 |
